NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) Depletions: What Pain Relief Medications Deplete

NSAIDs are among the most consumed medications worldwide, with approximately 30 million prescription NSAID fills and an estimated 30 billion over-the-counter doses taken annually in the United States alone. The class includes [ibuprofen](/medications/ibuprofen) (Advil, Motrin), [naproxen](/medications/naproxen) (Aleve), [aspirin](/medications/aspirin), and [celecoxib](/medications/celecoxib) (Celebrex). All NSAIDs share a common mechanism: inhibiting cyclooxygenase (COX) enzymes that produce prostaglandins — the chemical messengers responsible for inflammation, pain, and fever. The problem is that prostaglandins also maintain the protective mucus layer in the stomach, regulate kidney blood flow, and support platelet function. By blocking prostaglandin production system-wide, NSAIDs deliver pain relief at the cost of disrupting multiple protective pathways. CTD documents 455 chemical-gene interactions across the NSAID class and 8,351 disease associations, with FAERS reporting 28,844 adverse events for ibuprofen alone (46.4% serious).

The nutrient depletion profile of NSAIDs centers on three nutrients depleted through three distinct mechanisms. Iron depletion occurs because prostaglandin inhibition strips the stomach's protective mucus barrier, causing microscopic gastrointestinal bleeding in up to 70% of chronic users — even at standard OTC doses. This silent blood loss gradually drains iron stores over weeks and months, often without any visible bleeding that would prompt medical attention. CTD documents 276 gene interactions for ibuprofen alone, many involving iron transport pathways including ABCB1 and transferrin receptor mechanisms. Folate depletion results from NSAID-induced mucosal damage in the small intestine that impairs absorption, compounded by increased urinary folate excretion, particularly pronounced with aspirin therapy. Vitamin C depletion follows from the increased oxidative burden NSAIDs impose — as tissues attempt to repair prostaglandin-mediated damage, vitamin C stores are consumed as the body's primary water-soluble antioxidant, plus aspirin specifically increases urinary vitamin C losses.

Chronic NSAID users face a slow-moving nutritional crisis that rarely gets traced back to the pill bottle. Iron deficiency progresses through stages: first ferritin (stored iron) drops below 30 ng/mL, then transferrin saturation falls, and eventually hemoglobin declines into frank anemia. Patients describe feeling "drained and anemic" with easy bruising and dark stools. Menstruating women and adults over 65 face five-fold increased GI bleeding risk with chronic NSAID use, making these demographics especially vulnerable to iron depletion. Folate deficiency presents as fatigue, cognitive fog, and elevated homocysteine, particularly dangerous in the estimated 15 million Americans taking NSAIDs alongside methotrexate for rheumatoid arthritis, where folate depletion compounds from both drugs simultaneously. PharmGKB identifies CYP2C9 genetic variations — affecting approximately 35% of the population — that alter NSAID metabolism and potentially change depletion severity. Vitamin C depletion impairs wound healing and immune response, creating a cycle where inflammation persists despite NSAID therapy. The demographic most affected includes adults aged 40-70 with arthritis who take daily NSAIDs for months or years without any nutrient monitoring.

Proactive monitoring can catch these depletions before they produce symptoms. [Ferritin](/biomarkers/ferritin) testing every 6 months is critical for chronic NSAID users, with action thresholds at 50 ng/mL (the optimal range for energy and cognition, far above the lab "normal" floor of 15 ng/mL). The complete [iron panel](/biomarkers/iron-panel) — including transferrin saturation and total iron-binding capacity — provides a fuller picture when ferritin alone is ambiguous. Iron bisglycinate (better tolerated than ferrous sulfate) taken with vitamin C on an empty stomach and timed away from NSAID doses addresses iron depletion without worsening GI irritation. [Folate](/nutrients/folate) should be supplemented as L-methylfolate at 400-800 mcg daily, particularly for patients also taking methotrexate or carrying MTHFR genetic variants. Vitamin C at 500-1,000 mg daily supports antioxidant reserves and enhances iron absorption. Patients experiencing unexplained fatigue, easy bruising, or progressive GI symptoms should discuss these monitoring strategies with their healthcare provider rather than simply reaching for a higher NSAID dose.